More On Influenza



Seattle biotech nonprofit lands funding to improve vaccine responses


Better vaccines are goal of this local researcher. His institute just got more funding.


AAHI Receives up to $12.7 Million to Develop Novel NanoAlum Adjuvant Formulation for Better Protection Against Tuberculosis and Pandemic Influenza


Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen


Seattle institute lands $9.9M to develop nasal spray vaccine against bird flu


AAHI Announces $3M Award to Develop an Intranasal Pan-Viral Countermeasure against Respiratory Viruses

Page [tcb_pagination_current_page] of [tcb_pagination_total_pages]